Melbourne Biotech group wins Chinese investorTUESDAY, 4 OCT 2005 11:44AMMelbourne's reputation as a biotech investment hub continues to grow with the recent awarding of a $3 million investment from a Chinese company to Melbourne based herbal medicine and therapeutic science group R&D. |
Editor's Choice
Members' attitude, behaviour key to better engagement
New research suggests superannuation funds need to focus more on attitudinal and behavioural insights if they're to improve engagement.
Australia requires swifter settlement cycle: SIAA
Australia is at risk of getting left behind if it does not adopt the T+1 settlement cycle along with major global financial centres, according to operations experts.
Industry reacts to Federal Budget
Treasurer Jim Chalmers handed down the Federal Budget last night. Here's how the industry has reacted.
Budget 2024: Regulators given boost to combat misconduct, cybersecurity
The government will provide $17.3 million over four years to ASIC and APRA to combat greenwashing and other related financial misconduct and help further develop Australia's sustainable finance market.
Products
Expert Feed
Why advisers should consider offering general insurance to HNW clients
I have read many articles over the years about servicing high-net-worth (HNW) clients in the financial services industry.
The role of AI in financial planning: Insights from the US
Ever since ChatGPT burst onto the scene late last year, generative AI has been front and centre of business discussions and financial planning, just like ...
Considerations when nominating a charity for your super upon death
There has been a lot of talk lately about the upcoming great wealth transfer, and you might be wondering where charities fit into all this.
The end of free money
With institutional investors prudently reassessing their risks in current market conditions and seeking safe havens in alternatives such as secured private ...
Featured Profile
Robert De Dominicis
CHIEF EXECUTIVE OFFICER
GBST HOLDINGS LIMITED
GBST HOLDINGS LIMITED
It was during a family sojourn to the seaside town of Pescara, Italy, Rob DeDominicis first laid eyes on what would become the harbinger of his future. Andrew McKean writes.
